Home › Funds › TOCQUEVILLE ASSET MANAGEMENT L.P. › UTHR
TOCQUEVILLE ASSET MANAGEMENT L.P. position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
TOCQUEVILLE ASSET MANAGEMENT L.P. reported holding 83,237 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$45.1M, representing 0.68% of its reported portfolio and ranking #38 among its reported holdings. TOCQUEVILLE ASSET MANAGEMENT L.P. has disclosed UTHR holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How TOCQUEVILLE ASSET MANAGEMENT L.P.'s UTHR position evolved
TOCQUEVILLE ASSET MANAGEMENT L.P. first disclosed a stake in UTHR in Q2 2025 at 62,233 shares (US$17.9M). The position peaked in Q3 2026 at 83,237 shares, worth US$45.1M. Across 6 filings, TOCQUEVILLE ASSET MANAGEMENT L.P. increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 83,237 shares valued at US$45.1M — an increase of 11,359 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 62.23K | $17.88M | New |
| Q3 2025 | 61.74K | $25.88M | Reduce |
| Q4 2025 | 61.14K | $29.79M | Reduce |
| Q1 2026 | 60.28K | $35.75M | Reduce |
| Q2 2026 | 71.88K | $38.95M | Add |
| Q3 2026 | 83.24K | $45.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 38 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.68M sh · $908.15M · Q3 2026
- ASSETMARK, INC 600.17K sh · $325.23M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on TOCQUEVILLE ASSET MANAGEMENT L.P.
FAQ
How long has TOCQUEVILLE ASSET MANAGEMENT L.P. held UTHR?
TOCQUEVILLE ASSET MANAGEMENT L.P. has disclosed UTHR holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is TOCQUEVILLE ASSET MANAGEMENT L.P.'s current position in UTHR?
As of Q3 2026, TOCQUEVILLE ASSET MANAGEMENT L.P. holds 83.24K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $45.11M, representing 0.68% of its reported portfolio and ranking #38.
Has TOCQUEVILLE ASSET MANAGEMENT L.P. been buying or selling UTHR?
In the latest 13F filing (Q3 2026), TOCQUEVILLE ASSET MANAGEMENT L.P. increased its position in UTHR. The position peaked in Q3 2026 at 83.24K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.